Avanos Medical to acquire OrthogenRx for up to $160 million

Avanos Medical Inc. entered into a merger agreement to acquire OrthogenRx, Inc. for $130 million in cash at closing, plus up to $30 million in contingent consideration based on 2022 and 2023 net sales. The merger is expected to close in Q1 2022.

“The total purchase price payable by the Company in the Merger is $130.0 million in cash at closing, on a cash-free, debt-free basis and subject to adjustments based on the net working capital of OrthogenRx at the closing, plus up to an additional $30.0 million in contingent cash consideration based ”marketscreener.com

• 1 source
• marketscreener.comAVANOS MEDICAL, INC. : Entry into a Material Definitive Agreement (form 8-K) | MarketScreenerAcquiremediaDec 13, 2021

Summarized from public sources; check the original articles before acting on it.